Lunai Bioworks LNAI
NASDAQ LNAI
$1.77 -0.07 (-3.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) EBITDA Margin (2013 - 2026)

Updated

Lunai Bioworks (LNAI) reported EBITDA Margin of -6961.01% for fiscal Q3 2026 (quarter ended Mar 31, 2026).

Analysis

Lunai Bioworks (LNAI) EBITDA Margin (2013 - 2026) Analysis & Trends

Over the twelve months ended Mar 31, 2026, Lunai Bioworks' EBITDA Margin came in at -156549.81%; for FY2016 (ended Jun 30, 2016), it was -4894.98%.

  • EBITDA Margin has a four-year change of -1921.65 percentage points (FY2012 to FY2016).
  • By fiscal year, EBITDA Margin came in at -2154.98% in FY2015, -5189.97% in FY2013 (-2216.65 pp) and -2973.33% in FY2012.
  • The fiscal Q3 2026 figure ranks as the highest quarterly EBITDA Margin since fiscal Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 Lunai Bioworks 5.81 Mn 1.06 Mn 20,942.00 -6,961.01%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -6,961.01%
Dec 31, 2015 -1,399.04%
Sep 30, 2013 -36,676.86%
Mar 31, 2013 -521.60%
API Access

Lunai Bioworks EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LNAI&period=max&api_key=YOUR_API_KEY